MOR agonist-2

• Target:

  Opioid Receptor|||Dopamine Receptor

• Related Pathways:

  Endocrinology/Hormones|||GPCR/G Protein|||Neuroscience

• Bioactivity:

  Compound 46, designated as MOR agonist-2, serves as a D3R antagonist and a MOR agonist with respective K i values of 7.26 nM and 564 nM. This compound holds potential for analgesic effects attributed to its partial agonism at MOR and may decrease opioid misuse liability owing to its antagonistic action at D3R [1].

• Molecular Formula:

  C37H47Cl2N5O3

• Molecular Weight:

  680.71

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C